

A provider's guide to helping patients afford Droxidopa. Covers generic options, copay assistance, PAPs, coupons, and prior authorization strategies.
Droxidopa (brand name Northera) is one of only two FDA-approved treatments for neurogenic orthostatic hypotension (nOH), yet its cost can be a significant barrier to adherence. Brand-name Northera carries a retail price of approximately $2,721 for 90 capsules, and even with insurance, many patients face high specialty tier copays that can reach hundreds of dollars per fill.
The good news for providers and patients alike: generic Droxidopa is now available and can cost as little as $36.90 with a GoodRx coupon. Combined with manufacturer programs, patient assistance, and strategic prescribing, there are multiple pathways to make this medication affordable. This guide covers every tool available to help your patients access Droxidopa without financial hardship.
The most impactful step you can take is prescribing generic Droxidopa when clinically appropriate. Generic capsules are available from multiple manufacturers in all three strengths (100mg, 200mg, and 300mg) and are FDA-approved as therapeutically equivalent to Northera.
Key pricing benchmarks for generic Droxidopa:
When writing prescriptions, allow generic substitution unless there is a specific clinical reason to require brand-name Northera. Most patients will see a cost reduction of over 95% by switching to generic.
For patients paying cash or facing high copays, prescription discount cards can provide substantial savings on generic Droxidopa. Recommend that patients compare prices across multiple platforms:
Important note for providers: coupon cards cannot be used with government insurance (Medicare, Medicaid, Tricare). For those patients, see the patient assistance program section below.
Lundbeck offers the Northera Commercial Copay Assistance Program for eligible commercially insured patients who are prescribed brand-name Northera. Key details:
If your patient requires brand-name Northera (for example, due to a documented adverse reaction to a generic formulation), this program can significantly reduce their out-of-pocket costs.
For patients who are uninsured, underinsured, or on government insurance with high out-of-pocket costs, patient assistance programs may provide Droxidopa at no cost or significantly reduced cost:
As the prescribing provider, you may need to complete paperwork or provide documentation of medical necessity for these programs. Having your office staff familiar with the application process can save significant time.
Most insurance plans require prior authorization (PA) for Droxidopa, whether brand or generic. A denied or delayed PA is one of the most common reasons patients go without their medication. Here's how to streamline the process:
Include the following in every PA submission:
If the initial PA is denied:
Where you send the prescription can significantly affect both cost and access:
When possible, direct patients to the pharmacy that offers the best combination of availability and price. Use MedFinder for Providers to help patients check real-time pharmacy stock.
During Droxidopa shortage periods, limited supply can drive up costs at some pharmacies. Strategies for these situations:
For the latest supply information, see our Droxidopa shortage update or the provider's guide to finding Droxidopa in stock.
Integrating cost discussions into your clinical workflow ensures no patient falls through the cracks:
For patient-facing savings information, direct your patients to our guide on how to save money on Droxidopa. For additional provider resources on Droxidopa prescribing, including dosing guidelines, side effect management, and drug interactions, explore our full Droxidopa resource library at medfinder.com/providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.